pakistan
US FDA taps Szarama as acting head of vaccine unit
Key takeaways
- The appointment comes days after FDA Commissioner Marty Makary said no decision had been reached on Prasad’s permanent successor and that he expected an announcement “in the coming weeks.”
- Szarama will lead the Center for Biologics Evaluation and Research (CBER), which regulates vaccines, gene therapies and the blood supply.
- Prasad left the agency after a term marked by controversy, including several high-profile decisions on rare disease drugs and vaccines.
Why this matters: local context for readers following news across Pakistan and the region.
Add ARY News on Google The US Food and Drug Administration has named Katherine Szarama as the acting director of its vaccines and biologics unit, a Health and Human Services official told Reuters on Friday, replacing Vinay Prasad, whose turbulent tenure came to an end this week.
The appointment comes days after FDA Commissioner Marty Makary said no decision had been reached on Prasad’s permanent successor and that he expected an announcement “in the coming weeks.”
Szarama will lead the Center for Biologics Evaluation and Research (CBER), which regulates vaccines, gene therapies and the blood supply.
Article preview — originally published by ARY News. Full story at the source.
Read full story on ARY News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from ARY News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop